Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · IEX Real-Time Price · USD
35.41
+0.11 (0.31%)
At close: Mar 28, 2024, 4:00 PM
35.40
-0.01 (-0.03%)
After-hours: Mar 28, 2024, 7:53 PM EDT
0.31%
Market Cap 2.33B
Revenue (ttm) 747.72M
Net Income (ttm) -222.61M
Shares Out 65.63M
EPS (ttm) -3.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,667,868
Open 35.55
Previous Close 35.30
Day's Range 35.06 - 36.09
52-Week Range 13.82 - 43.52
Beta 1.08
Analysts Buy
Price Target 36.00 (+1.67%)
Earnings Date May 1, 2024

About TNDM

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and deliverin... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 14, 2013
Employees 2,400
Stock Exchange NASDAQ
Ticker Symbol TNDM
Full Company Profile

Financial Performance

In 2023, TNDM's revenue was $747.72 million, a decrease of -6.68% compared to the previous year's $801.22 million. Losses were -$222.61 million, 135.3% more than in 2022.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for TNDM stock is "Buy." The 12-month stock price forecast is $36.0, which is an increase of 1.67% from the latest price.

Price Target
$36.0
(1.67% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $275.0 million aggregate principal amou...

23 days ago - Business Wire

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions...

24 days ago - Business Wire

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter...

5 weeks ago - Business Wire

Tandem Diabetes Care Launches Tandem Mobi, the World's Smallest, Durable Automated Insulin Delivery System

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Mobi, the world's smallest, durable automated insulin delivery system for people living with diabetes, now shipping in the United States.

6 weeks ago - Business Wire

Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a comp...

7 weeks ago - Business Wire

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2...

2 months ago - Business Wire

Tandem Diabetes Care's t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott's New FreeStyle Libre® 2 Plus Sensor

ABBOTT PARK, Ill. & SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Abbott (NYSE: ABT), the global health care company, and Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diab...

Other symbols: ABT
2 months ago - Business Wire

Tandem is expected to have a lot of upside in 2024, says Jefferies' Matthew Taylor

Matthew Taylor, senior analyst at Jefferies, joins 'The Exchange' to discuss the outlook for the med tech market, his top picks for 2024, and more.

3 months ago - CNBC Television

Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a di...

3 months ago - Business Wire

Tandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--Tandem Diabetes Care today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 CGM integration in the United States.

4 months ago - Business Wire

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of invest...

5 months ago - Business Wire

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Tandem Investors of a Lead Plaintiff Deadline of November 7, 2023

NEW YORK , Nov. 6, 2023 /PRNewswire/ -- Attention Tandem Diabetes Care, Inc. ("Tandem") (NASDAQ: TNDM) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced ...

5 months ago - PRNewsWire

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 6, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

FINAL DEADLINE TUESDAY: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM

NEW YORK , Nov. 3, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM). Such investors are advise...

5 months ago - PRNewsWire

TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit

LOS ANGELES , Nov. 3, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit again...

5 months ago - PRNewsWire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 3, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Tandem Diabetes Care, Inc.(TNDM) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Tandem Diabetes Care, Inc. ("Tandem" or the "Company") (NASDAQ: TNDM) of a class action securities lawsuit. CLASS DE...

5 months ago - PRNewsWire

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 2, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as E...

5 months ago - Business Wire

Tandem Diabetes Care Announces Third Quarter 2023 Financial Results

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter...

5 months ago - Business Wire

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Tandem Diabetes Care, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 31, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tandem Diabetes Care, Inc. ("T...

5 months ago - Accesswire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)

NEW YORK , Oct. 31, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Tandem Diabetes Care, Inc.. Shareholders who purchased shares of TNDM during the class period...

5 months ago - PRNewsWire

TNDM NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM

NEW YORK , Oct. 30, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 a...

5 months ago - PRNewsWire